|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
3D Molecular Sciences Ltd., of Cambridge, UK, named Elizabeth Hill CEO. Previously, she operated her own consulting business. 3D is looking to commercialize a particle-based assay platform designed for large-scale genomic and proteomic analysis.
Advanced Viral Research Corp., of Yonkers, N.Y., said James Dicke, a member of its board, purchased $1 million of its convertible debentures in a private placement, while business advisory board member Peter Lunder purchased $500,000 worth. The principal balance is convertible into shares of common stock as follows: 20 percent on the original issue date and an additional 20 percent every six months thereafter.
...